Detect
Founded 2025 · 88 employees on LinkedIn · 2 known investors
Detect develops molecular diagnostic tests that combine nucleic acid amplification with lateral flow hardware to deliver PCR-level accuracy without lab work, returning results in about one hour. Its consumer testing platform started with COVID-19 detection and is designed to adapt to other pathogens, with stated ambitions in women's health diagnostics.
Investors · 2
Frequently asked questions
- What does Detect do?
- Detect develops molecular diagnostic tests that combine nucleic acid amplification with lateral flow hardware to deliver PCR-level accuracy without lab work, returning results in about one hour. Its consumer testing platform started with COVID-19 detection and is designed to adapt to other pathogens, with stated ambitions in women's health diagnostics.
- Who are Detect's investors?
- Detect's investors include Expa, Horizons Ventures.